123 related articles for article (PubMed ID: 9408157)
1. Resistance pattern of 2816 isolates isolated from 17631 blood cultures and etiology of bacteremia and fungemia in a single cancer institution.
Trupl J; Kunová A; Oravcová E; Pichna P; Kukucková E; Grausova S; Grey E; Spanik S; Demitrovicová A; Kralóvicová K; Lacka J; Krupova I; Svec J; Koren P; Krcméry V
Acta Oncol; 1997; 36(6):643-9. PubMed ID: 9408157
[TBL] [Abstract][Full Text] [Related]
2. Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.
Krupova I; Kaiserova E; Foltinova A; Kovacicova G; Kiskova M; Krchnakova A; Kunova A; Trupl J; West D; Krcmery V
J Chemother; 1998 Jun; 10(3):236-42. PubMed ID: 9669650
[TBL] [Abstract][Full Text] [Related]
3. Antibiotic use and development of resistance in blood culture isolates: 8 years of experience from a cancer referral center.
Krcméry V; Sykora P; Trupl J; Kunova A; Sabo A; Jurga L; Novotny J; Mateicka F; Babela R; Pichnova E; Gould IM
J Chemother; 2001 Apr; 13(2):133-42. PubMed ID: 11330359
[TBL] [Abstract][Full Text] [Related]
4. Bacteremia and fungemia occurring during antimicrobial prophylaxis with ofloxacin in cancer patients: risk factors, etiology and outcome.
Spanik S; Trupl J; Ilavska I; Helpianska L; Drgona L; Demitrovicova A; Kukuckova E; Studena M; Pichna P; Oravcova E; Rusnakova V; Koren P; Lacka J; Krcmery V
J Chemother; 1996 Oct; 8(5):387-93. PubMed ID: 8957720
[TBL] [Abstract][Full Text] [Related]
5. Eight-year surveillance of non-albicans Candida spp. in an oncology department prior to and after fluconazole had been introduced into antifungal prophylaxis.
Kunova A; Trupl J; Demitrovicova A; Jesenska Z; Grausova S; Grey E; Pichna P; Kralovicova K; Sorkovska D; Krupova I; Spanik S; Studena M; Koren P; Krcmery V
Microb Drug Resist; 1997; 3(3):283-7. PubMed ID: 9271000
[TBL] [Abstract][Full Text] [Related]
6. Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.
Spanik S; Trupl J; Kunova A; Botek R; Sorkovska D; Grey E; Studena M; Lacka J; Oravcova E; Krchnakova A; Rusnakova V; Svec J; Krupova I; Grausova S; Stopkova K; Koren P; Krcmery V
Scand J Infect Dis; 1997; 29(3):245-9. PubMed ID: 9255883
[TBL] [Abstract][Full Text] [Related]
7. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
[TBL] [Abstract][Full Text] [Related]
8. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia.
Benjamin DK; Ross K; McKinney RE; Benjamin DK; Auten R; Fisher RG
Pediatrics; 2000 Oct; 106(4):712-8. PubMed ID: 11015513
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of catheter-related fungemia and bacteremia.
Inoue Y; Kohno S; Fujii T; Otsubo T; Mori N; Ishino T; Takase T; Kaku M; Koga H; Hara K
Intern Med; 1995 Jun; 34(6):485-90. PubMed ID: 7549129
[TBL] [Abstract][Full Text] [Related]
10. Candida krusei fungemia. An escalating serious infection in immunocompromised patients.
Abbas J; Bodey GP; Hanna HA; Mardani M; Girgawy E; Abi-Said D; Whimbey E; Hachem R; Raad I
Arch Intern Med; 2000 Sep; 160(17):2659-64. PubMed ID: 10999981
[TBL] [Abstract][Full Text] [Related]
11. Fluconazole resistance of Candida krusei.
Manso E; Montillo M; Discepoli G; Leoni P
Boll Ist Sieroter Milan; 1991-1992; 70(1-2):527-9. PubMed ID: 1670057
[TBL] [Abstract][Full Text] [Related]
12. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence and antimicrobial susceptibility patterns of microorganisms causing bacteremia and fungemia in pediatric oncology patients].
Cheguirián ML; Carvajal LR; Ledesma EM; Enrico MC; Reale AL; Culasso C; Bertoni L
Rev Argent Microbiol; 2008; 40(2):111-5. PubMed ID: 18705494
[TBL] [Abstract][Full Text] [Related]
14. Case report 6: Candidaemia in a high risk liver transplant recipient.
Cervera C; Linares L; Reverté E; Escorsell A; Moreno A
Mycoses; 2010 Jul; 53 Suppl 2():14-5. PubMed ID: 20591016
[No Abstract] [Full Text] [Related]
15. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
Nguyen MH; Peacock JE; Morris AJ; Tanner DC; Nguyen ML; Snydman DR; Wagener MM; Rinaldi MG; Yu VL
Am J Med; 1996 Jun; 100(6):617-23. PubMed ID: 8678081
[TBL] [Abstract][Full Text] [Related]
16. Risk factors, aetiology, therapy and outcome in 123 episodes of breakthrough bacteraemia and fungaemia during antimicrobial prophylaxis and therapy in cancer patients.
Spanik S; Trupl J; Kunova A; Drgona L; Salek T; Mardiak J; Kukuckova E; Studena M; Pichna P; Oravcova E; Grey E; Koren P; Svec J; Lacka J; Sufliarsky J; Krcmery V
J Med Microbiol; 1997 Jun; 46(6):517-23. PubMed ID: 9350206
[TBL] [Abstract][Full Text] [Related]
17. Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Krupova Y; Novotny J; Sabo A; Mateicka F; Krcmery V
Int J Antimicrob Agents; 1998 Nov; 10(4):313-6. PubMed ID: 9916907
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia.
Persson L; Vikerfors T; Sjöberg L; Engervall P; Tidefelt U
Scand J Infect Dis; 2000; 32(6):615-21. PubMed ID: 11200370
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial bloodstream infections in United States hospitals: a three-year analysis.
Edmond MB; Wallace SE; McClish DK; Pfaller MA; Jones RN; Wenzel RP
Clin Infect Dis; 1999 Aug; 29(2):239-44. PubMed ID: 10476719
[TBL] [Abstract][Full Text] [Related]
20. Blood culture Gram stain and simple clinical categorisation can be used to identify patients at risk for delay in appropriate antibiotic treatment.
Veijola S; Burtonwood M; Stapf J; Kauma H; Kauppila J; Koskela M; Hautala T
Int J Antimicrob Agents; 2008 Dec; 32(6):546-7. PubMed ID: 18789847
[No Abstract] [Full Text] [Related]
[Next] [New Search]
